ATOS

ATOS

USD

Atossa Therapeutics Inc. Common Stock

$0.900+0.060 (7.143%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.840

High

$0.900

Low

$0.840

Volume

0.64M

Company Fundamentals

Market Cap

116.3M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.96M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.55Current $0.900High $1.66

Related News

Analyst Upgrades

Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.5

Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics with a Buy and raises the price target from $7.25 to $7.5.

View more
Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.5
Analyst Upgrades

Craig-Hallum Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $4

Craig-Hallum analyst Albert Lowe initiates coverage on Atossa Therapeutics with a Buy rating and announces Price Target of $4.

View more
Craig-Hallum Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $4
PR Newswire

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for...

View more
Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference